title: Integration of single-layer skin hollow fibers and scaffolds develops a three-dimensional hybrid bioreactor for bioartificial livers.
abstract: Bioartificial liver support systems are expected to be an effective therapy as a "bridge" for liver transplantation or reversible acute liver disease. A major roadblock in the application of bioartificial livers is the need for a bioreactor that fully meets the requirements of hepatocyte culture, mass transfer and immunobarriers. In this study, we developed a three-dimensional hybrid bioreactor (3DHB) on a base of single-layer skin polyethersulfone hollow fibers by integrating with polyurethane scaffolds. The mass transfer of bilirubin and albumin from the intracapillary space to the extracapillary space of the hollow fibers was not significantly different between 3DHBs and hollow fiber bioreactors (HFBs). Cell viability staining showed that high-density hepatocytes were uniformly found in different regions of the 3DHB after 7 days of culture. Liver-specific functions of human mature hepatocytes cultured in the 3DHB, such as albumin secretion, urea production, ammonia removal rate and cytochrome P450 activity, were maintained stably and were significantly higher compared with the HFB. These results indicated that the 3DHB has good mass transfer and improves cell distribution and liver-specific functions. Meanwhile, the ammonia and unconjugated bilirubin concentrations in plasma from patients with liver failure were significantly decreased during 6 h of circulation by hepatocytes cultured in the 3DHB. Most hepatocytes in the 3DHB were viable after 6 h exposure to the patient plasma. We further demonstrated that bioartificial liver systems with 3DHB can remove toxins from and endure the deleterious effects of the patient plasma. Therefore, the 3DHB has the potential to accomplish different actions for the clinical application of bioartificial livers.
authors: Institute of Infectious Diseases, Southwest Hospital, Third Military Medical University, Chongqing, 400038, China, zhangshich@gmail.com.
authors: Shichang
authors: S
authors: Zhang
authors: Li
authors: L
authors: Chen
authors: Tao
authors: T
authors: Liu
authors: Zhengguo
authors: Z
authors: Wang
authors: Yingjie
authors: Y
authors: Wang
mesh_terms: D000641:Ammonia / Q000097:blood / Q000378:metabolism; D001663:Bilirubin / Q000097:blood / Q000378:metabolism; D019149:Bioreactors; D002470:Cell Survival; D004867:Equipment Design; D022781:Hepatocytes / Q000166:cytology / Q000378:metabolism; D006801:Humans; D017114:Liver Failure, Acute / Q000097:blood / Q000628:therapy; D019164:Liver, Artificial; D008422:Materials Testing; D054457:Tissue Scaffolds
chemical_list: D000641:Ammonia; D001663:Bilirubin
references: Ann Surg. 2004 May;239(5):660-7; discussion 667-70
references: 15082970
references: Artif Organs. 2001 Mar;25(3):194-200
references: 11284886
references: Cell Transplant. 2001;10(8):717-22
references: 11814114
references: Hepatology. 2004 Dec;40(6):1275-84
references: 15562440
references: Liver Transpl. 2011 Feb;17(2):104-14
references: 21280182
references: Int J Artif Organs. 2007 Mar;30(3):183-91
references: 17417756
references: Liver Int. 2013 Apr;33(4):516-24
references: 23387413
references: Hepatology. 1995 Aug;22(2):546-52
references: 7635423
references: Cells Tissues Organs. 2001;168(3):170-7
references: 11173802
references: Artif Organs. 2003 Jul;27(7):613-22
references: 12823416
references: World J Gastroenterol. 2005 Dec 28;11(48):7585-90
references: 16437682
references: Tissue Eng. 2006 Jul;12(7):1881-90
references: 16889518
references: ASAIO J. 2004 Sep-Oct;50(5):491-7
references: 15497391
references: Tissue Eng. 2005 Nov-Dec;11(11-12):1667-77
references: 16411812
references: Liver Int. 2007 Dec;27(10):1333-41
references: 18036098
references: Hepatology. 1994 May;19(5):1133-40
references: 8175134
references: Cell Transplant. 2003;12(6):563-8
references: 14579924
references: Acta Biomater. 2011 Sep;7(9):3370-81
references: 21658478
references: Tissue Eng Part A. 2012 Jul;18(13-14):1352-64
references: 22519429
references: Biomaterials. 2006 Jul;27(20):3836-45
references: 16527346
references: Hepatology. 2010 Jan;51(1):297-305
references: 19998274
references: Science. 2002 Feb 8;295(5557):1005-9
references: 11834813
references: Tissue Eng Part A. 2012 Nov;18(21-22):2376-85
references: 22712633
references: Nat Biotechnol. 2006 Nov;24(11):1412-9
references: 17086173
references: Cells Tissues Organs. 2001;169(1):34-41
references: 11340259
references: Cell Transplant. 2006;15(10):873-80
references: 17299991
references: J Biomater Sci Polym Ed. 2007;18(1):45-58
references: 17274450
references: J Hepatol. 2006 Feb;44(2):317-24
references: 16356580
references: J Biotechnol. 2010 Aug 2;148(4):226-32
references: 20540974
references: Biomaterials. 2005 May;26(15):2509-16
references: 15585253
references: Ann Surg. 2004 Aug;240(2):216-30
references: 15273544
references: Gut. 2009 Dec;58(12):1690-702
references: 19923348
references: Acta Biomater. 2011 Sep;7(9):3312-24
references: 21704736
references: Int J Artif Organs. 2002 Oct;25(10):950-9
references: 12456036
references: Methods Mol Biol. 2009;481:17-23
references: 19096797
references: Biotechnol Bioeng. 2010 Aug 15;106(6):980-8
references: 20506230
references: Am J Pathol. 2005 Nov;167(5):1279-92
references: 16251412
references: Biomaterials. 2009 May;30(13):2531-43
references: 19185912
references: Hepatology. 2001 Sep;34(3):447-55
references: 11526528
references: J Mater Sci Mater Med. 2012 Aug;23(8):2001-11
references: 22584823
references: J Biomater Appl. 2012 Sep;27(3):359-66
references: 21750186
references: Tissue Eng Part C Methods. 2009 Sep;15(3):345-53
references: 19196126
references: Cell Transplant. 1999 Sep-Oct;8(5):531-41
references: 10580347
references: Tissue Eng. 2004 Jul-Aug;10(7-8):1113-24
references: 15363168